5OC8
HDM2 (17-111, WILD TYPE) COMPLEXED WITH NVP-HDM201 AT 1.56A
Summary for 5OC8
Entry DOI | 10.2210/pdb5oc8/pdb |
Related | 5LN2 |
Descriptor | E3 ubiquitin-protein ligase Mdm2, (4~{S})-5-(5-chloranyl-1-methyl-2-oxidanylidene-pyridin-3-yl)-4-(4-chlorophenyl)-2-(2,4-dimethoxypyrimidin-5-yl)-3-propan-2-yl-4~{H}-pyrrolo[3,4-d]imidazol-6-one, CHLORIDE ION, ... (4 entities in total) |
Functional Keywords | ppi with p53, inhibitor complex, cell cycle, ligase |
Biological source | Homo sapiens (Human) |
Total number of polymer chains | 1 |
Total formula weight | 11746.92 |
Authors | Kallen, J. (deposition date: 2017-06-29, release date: 2018-08-22, Last modification date: 2024-01-17) |
Primary citation | Jeay, S.,Ferretti, S.,Holzer, P.,Fuchs, J.,Chapeau, E.A.,Wartmann, M.,Sterker, D.,Romanet, V.,Murakami, M.,Kerr, G.,Durand, E.Y.,Gaulis, S.,Cortes-Cros, M.,Ruetz, S.,Stachyra, T.M.,Kallen, J.,Furet, P.,Wurthner, J.,Guerreiro, N.,Halilovic, E.,Jullion, A.,Kauffmann, A.,Kuriakose, E.,Wiesmann, M.,Jensen, M.R.,Hofmann, F.,Sellers, W.R. Dose and Schedule Determine Distinct Molecular Mechanisms Underlying the Efficacy of the p53-MDM2 Inhibitor HDM201. Cancer Res., 78:6257-6267, 2018 Cited by PubMed: 30135191DOI: 10.1158/0008-5472.CAN-18-0338 PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (1.56 Å) |
Structure validation
Download full validation report